StonvexLoading…
StonvexStonvexStonvexCore line items from AAMI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $167.00M | $563.70M | $391.50M | $247.30M |
Operating Income | $41.90M | $132.10M | $74.70M | $48.10M |
Net Income | $24.30M | $80.00M | $45.30M | $30.20M |
EPS (Diluted) | $0.68 | $2.21 | $1.25 | $0.82 |
Total Assets | $715.40M | $677.00M | $751.40M | $672.30M |
Total Liabilities | $616.00M | $593.00M | $640.10M | $585.40M |
Cash & Equivalents | $150.00M | $124.40M | $138.70M | $93.90M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 35.76M | 36.22M | 36.38M | 36.65M |